Brief: Telesis Bio Reports Fourth Quarter Financial Results

Telesis Bio

21/03/2023 20:10

March 21 (Reuters) - Telesis Bio Inc  TBIO.O :
    * TELESIS BIO REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND PROVIDES 2023 GUIDANCE
    * Q4 REVENUE ROSE 208 PERCENT TO $9.5 MILLION
    * Q4 LOSS PER SHARE $0.28
    * SEES FY 2023 TOTAL REVENUE GREATER THAN $45 MILLION
    * CASH AND CASH EQUIVALENTS WERE $43.8 MILLION AS OF
DECEMBER 31,
2022
    * Q4 EARNINGS PER SHARE VIEW $-0.41, REVENUE VIEW $7.2
MILLION --
REFINITIV IBES DATA
    * FY2023 REVENUE VIEW $42.4 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX8GbqP2 
Further company coverage:  TBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))